Investors can no longer afford to ignore the devastating economic effects of biodiversity loss, but they need better tools to assess and manage the risks. We introduce the new scientific research by our academic partners at the MISTRA FinBio programme which should help guide investors.
Biodiversity loss has long concerned scientists and conservationists. But new research shows it has now started to become a material financial risk for listed companies and their investors. Several studies published in the past year have found that biodiversity-related risks are beginning to affect company valuations and their financing costs.